Amphastar Pharmaceuticals (AMPH) PT Lowered to $21 at Piper Sandler
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $22.01 +0.59%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $21.00 (from $25.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Freedom Broker Downgrades Workday (WDAY) to Hold
- Macquarie Downgrades Leader Harmonious Drive Systems (688017:CH) to Underperform
- Marvell (MRVL) PT Raised to $325 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
